Literature DB >> 21450216

Reasons to prescribe antipsychotics for the behavioral symptoms of dementia: a survey in Dutch nursing homes among physicians, nurses, and family caregivers.

Esther Cornegé-Blokland1, Bart C Kleijer, Cees M P M Hertogh, Rob J van Marum.   

Abstract

OBJECTIVES: Despite serious safety concerns, prescription rates of antipsychotics for the treatment of the behavioral and psychological symptoms of dementia remain high, especially in nursing homes. This high prevalence of antipsychotic use cannot be explained by the modest success rate reported in the literature. In this study, we aim at clarifying the reasons for prescribing an antipsychotic drug in behavioral and psychological symptoms of dementia and look at the role of nurses and family caregivers in the decision-making process that precedes the prescription of an antipsychotic drug.
DESIGN: Questionnaire used in a one-on-one interview with elderly care physicians, nurses, and family caregivers.
SETTING: We conducted a survey in 23 nursing homes in the Netherlands.
METHOD: On each dementia ward, the physician selected 1 or 2 patients who started antipsychotics most recently. An interviewer then held a structured questionnaire with the physician, the nurse, and the first relative of the patient. The first part of the interview consisted of questions about the general ideas of the physicians and the second part consisted of case-related questions to physicians, nurses, and family caregivers.
RESULTS: Physicians, nurses, and family caregivers generally consider the possible benefits of antipsychotics to outweigh the risk of side effects. The main reasons to start therapy are agitation and aggression. Physicians felt pressured by nurses to prescribe in 17% of cases. Physicians felt supported by the guideline of the Dutch Association of Elderly Care Physicians. The estimated average success rate in the discussed cases (the patient is expected to improve on the target behavior) among physicians was 50%, nurses reported 53%, and relatives 55%. The most frequently expected adverse reactions were increased fall risk, sedation, and parkinsonism. Nurses expected cognitive decline. The family felt insufficiently informed about the side effects in 44% of the cases.
CONCLUSION: The interviewed nursing home physicians and nurses expect almost half of their patients with dementia and behavioral disturbances to benefit from antipsychotic therapy. Serious side effects were expected to occur only sporadically. These expectations may contribute to the high rate of antipsychotic use among these patients.
Copyright © 2012 American Medical Directors Association, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21450216     DOI: 10.1016/j.jamda.2010.10.004

Source DB:  PubMed          Journal:  J Am Med Dir Assoc        ISSN: 1525-8610            Impact factor:   4.669


  14 in total

1.  Behavioral management in the person with dementia.

Authors:  J E Morley
Journal:  J Nutr Health Aging       Date:  2013-01       Impact factor: 4.075

Review 2.  Relationship between Organizational Culture and the Use of Psychotropic Medicines in Nursing Homes: A Systematic Integrative Review.

Authors:  Mouna Sawan; Yun-Hee Jeon; Timothy F Chen
Journal:  Drugs Aging       Date:  2018-03       Impact factor: 3.923

3.  Type and course of symptoms demonstrated in the terminal and dying phases by people with dementia in nursing homes.

Authors:  A Koppitz; G Bosshard; D H Schuster; H Hediger; L Imhof
Journal:  Z Gerontol Geriatr       Date:  2015-02       Impact factor: 1.281

4.  A consensus guideline for antipsychotic drug use for dementia in care homes. Bridging the gap between scientific evidence and clinical practice.

Authors:  Sytse U Zuidema; Alice Johansson; Geir Selbaek; Matt Murray; Alistair Burns; Clive Ballard; Raymond T C M Koopmans
Journal:  Int Psychogeriatr       Date:  2015-06-10       Impact factor: 3.878

5.  Factors Related to Rejection of Care and Behaviors Directed towards Others: A Longitudinal Study in Nursing Home Residents with Dementia.

Authors:  Francisca Galindo-Garre; Ladislav Volicer; Jenny T van der Steen
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2015-04-10

6.  Discontinuing inappropriate medication in nursing home residents (DIM-NHR Study): protocol of a cluster randomised controlled trial.

Authors:  Hans Wouters; Elise H Quik; Froukje Boersma; Peder Nygård; Judith Bosman; Wendelien M Böttger; Hans Mulder; Jan-Gerard Maring; Linda Wijma-Vos; Tim Beerden; Jasperien van Doormaal; Maarten J Postma; Sytse U Zuidema; Katja Taxis
Journal:  BMJ Open       Date:  2014-10-08       Impact factor: 2.692

7.  How Prolific is Psychotropic Medicines Use in People with Dementia in Australia Within the Community Setting? A Retrospective Analysis.

Authors:  Dianne Goeman; Kira Harvey; Cik Yin Lee; Neil Petrie; Chris Beanland; Christine Culhane; Susan Koch
Journal:  Drugs Real World Outcomes       Date:  2015-09

8.  Prevalence of, and Resident and Facility Characteristics Associated With Antipsychotic Use in Assisted Living vs. Long-Term Care Facilities: A Cross-Sectional Analysis from Alberta, Canada.

Authors:  Kathryn J Stock; Joseph E Amuah; Kate L Lapane; David B Hogan; Colleen J Maxwell
Journal:  Drugs Aging       Date:  2017-01       Impact factor: 3.923

9.  Prescribing of psychotropic medication for nursing home residents with dementia: a general practitioner survey.

Authors:  Justin M Cousins; Luke Re Bereznicki; Nick B Cooling; Gregory M Peterson
Journal:  Clin Interv Aging       Date:  2017-10-03       Impact factor: 4.458

10.  PROPER I: frequency and appropriateness of psychotropic drugs use in nursing home patients and its associations: a study protocol.

Authors:  Klaas van der Spek; Debby L Gerritsen; Martin Smalbrugge; Marjorie H J M G Nelissen-Vrancken; Roland B Wetzels; Claudia H W Smeets; Sytse U Zuidema; Raymond T C M Koopmans
Journal:  BMC Psychiatry       Date:  2013-11-15       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.